- Report
- January 2025
- 120 Pages
Global
€4990EUR$5,881USD£4,454GBP
- Report
- September 2024
- 118 Pages
Global
From €4090EUR$4,500USD£3,527GBP
- Report
- April 2021
China
From €2363EUR$2,600USD£2,038GBP
- Report
- November 2020
- 450 Pages
Global
From €4454EUR$4,900USD£3,841GBP
- Report
- March 2018
- 102 Pages
Global
From €2500EUR$2,750USD£2,156GBP
- Report
- October 2023
- 72 Pages
Global
From €3500EUR$4,125USD£3,124GBP
- Report
- October 2023
- 100 Pages
Global
From €3500EUR$4,125USD£3,124GBP
- Report
- November 2021
- 747 Pages
Global
From €3636EUR$4,000USD£3,135GBP

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body.
PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more